44
Growth Score in past quarter
pts
Heat Score 44 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1049630
Orbiton Theragnostics provides theranostic CDMO, research, and isotope supply services for nuclear medicine and precision cancer care.
About the Company
Orbiton Theragnostics provides integrated theranostic solutions for nuclear medicine companies and precision cancer care. The organization offers preclinical and clinical study services, including in‑vitro and in‑vivo studies, animal imaging, biodistribution, toxicity, and first‑in‑human clinical studies. It delivers contract research and
technology transfer CDMO services for radiopharmaceutical formulation, radiolabeling, and analytical method development. Orbiton also supports isotope manufacturing and supply for clinical trials, covering isotope formulations, dispensing, and radioactive drug manufacturing. In addition, it develops proprietary theranostic agents that combine diagnostics and therapy.